12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Avant, Megan Health Inc., Pfizer deal

AVAN will purchase Megan for 1.9 million AVAN shares valued at $14.3 million. AVAN said the acquisition adds to its vaccines portfolio, including technology for developing...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >